Cerevel Therapeutics to Present at the 43rd Annual Cowen

Cerevel Therapeutics to Present at the 43rd Annual Cowen

CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain......

Cerevel Therapeutics to Report Fourth Quarter and Full Year

Cerevel Therapeutics to Report Fourth Quarter and Full Year

CAMBRIDGE, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain......

menu
menu